Caxton Associates (New York)’s Allergan plc AGN Stock Holding History

Caxton Associates (New York)’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,174	Closed	-$916K	–	688
2020 Q1	$916K	Sell	5,174 -23,998	-82%	-$4.52M	0.17%	73
2019 Q4	$5.58M	Buy	+29,172	New	+$5.26M	0.76%	23
2019 Q1	–	Sell	-1,856	Closed	-$248K	–	523
2018 Q4	$248K	Buy	+1,856	New	+$304K	0.04%	216
2018 Q1	–	Sell	-2,100	Closed	-$344K	–	480
2017 Q4	$344K	Hold	2,100	–	–	0.02%	312
2017 Q3	$430K	Buy	+2,100	New	+$488K	0.02%	388

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Caxton Associates (New York)'s AGN Position: Q2 2020 in Review

Caxton Associates (New York) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,174 shares — an estimated $916K sold.

Caxton Associates (New York) first reported a position in AGN in Q3 2017 and held it in 5 quarters. The position peaked at $5.58M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Caxton Associates (New York) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Caxton Associates (New York) sold 5,174 Allergan plc shares in Q2 2020, an estimated $916K.
Caxton Associates (New York) first reported a position in Allergan plc in Q3 2017 and held it in 5 quarters.
Caxton Associates (New York)'s Allergan plc position peaked at $5.58M in Q4 2019.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Caxton Associates (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.